Hints and tips:
Related Special Reports
...The US-based group has raised $20.5bn for its seventh private equity fund....
...Grant Thornton’s retired US partners are demanding a greater share of the spoils from its sale of a majority stake to private equity, after accusing the accounting firm’s management of short-changing them...
...Retired US partners of Grant Thornton have stepped up their fight for a bigger share of the proceeds from the sale of the accounting firm, hiring lawyers to challenge management over the terms of the deal...
...Its shares have slipped since the start of the year, while rivals’ stocks have soared, adding pressure on the tech giant to announce game-changing AI features that could boost device sales....
...General Atlantic and CVC have paused multimillion-dollar stake sales in companies operating US fast food brands in Indonesia and Malaysia as protests and boycott campaigns over the Israel-Hamas war disrupt...
...Google reported $175bn in revenue from search and related ads last year, more than half its total sales, posing a conundrum for the company over how to embrace the latest AI innovations while preserving...
...The sale gives Baker Tilly US an enterprise value of more than $2bn and capital to fund what its chief executive Jeff Ferro called an “extremely aggressive” acquisition strategy, signalling the firm’s ambition...
...As markets hit record highs, the ratio of corporate insider selling to insider buying is at the highest level since the first quarter of 2021, according to Verity LLC, which tracks insider trading disclosures...
...It is part of a flurry of asset sales that have tided over LPs. Since early 2023, Silver Lake has struck deals to sell down $20bn in investments, the group told its investors....
...Not only did Apollo lose out, so did the merger arb funds: they would receive only 75 per cent of the €2.13 difference between the January sale to Apollo and the winning price....
...They certainly should after the entertainment group announced a long-expected go-private sale to its existing majority shareholders this week. The deal values Endeavor’s equity at $13bn....
...From the outset, the Fortress sale was structured to appease regulatory concerns....
...J&J’s medtech division has outstripped the growth of the company’s drugs and diagnostics business, generating $30.4bn in sales last year, or 35 per cent of group revenues....
...Novo Nordisk is lowering prices of its weight loss drug Wegovy as it boosts sales volumes and responds to higher competition from US rival Eli Lilly, leading to lower than expected quarterly revenue from...
...Curiously, the FTC gave scant mention to Walmart, which leads US grocery sales with 23.6 per cent of the market last year, according to analytics firm Numerator....
...“Doesn’t that tell us all we need to know in terms of barriers of entry?” he asked....
...The report also alleged the company seemed to have incorrectly booked sales of hardware as software and might have misrepresented the nature of its revenue....
...alleging that Handler was attempting to shake them down for money he did not deserve and that, regardless, whatever equity he had earned required him to be an employee at the time of a Centerview IPO or sale...
...Soriot set the goal to reach $45bn in sales by 2023 a decade ago, as part of its campaign to see off a £69.4bn hostile pursuit from US rival Pfizer. Back then AstraZeneca’s revenues were $26bn....
...In the US, more than 90 per cent of sales are completely or partially covered by health insurance, the company said....
...Sales at the company grew by 2.2 per cent to $1.4bn dollars, below analysts’ estimates, with the US accounting for almost half of total revenue....
...Naked short sales have been banned in the US since 2005. G1 declined to comment. Virtu and Jane Street did not immediately respond to requests for comment....
...Microsoft’s revenue in the quarter climbed 17 per cent to $61.9bn, driven by cloud computing sales and rampant demand for AI-related services on its Azure platform....
...The industry’s rise comes during a period of tense US-China relations and a rise in trade barriers, including sweeping controls of American technology sales to China....
...Dropping the 70 per cent discount is a boon for makers of cheaper drugs, such as cardiovascular medications....
International Edition